المؤلفون: Kaakour, Dalia, Ward, Garrett, Dayyani, Farshid

المصدر: Diseases. 10(2)

مصطلحات موضوعية: Biomedical and Clinical Sciences, Clinical Sciences, Oncology and Carcinogenesis, Rare Diseases, Cancer, Clinical Trials and Supportive Activities, Clinical Research, Digestive Diseases, 6.1 Pharmaceuticals, Evaluation of treatments and therapeutic interventions, checkpoint inhibitors, advanced gastric cancer, survival, durable remission, Biomedical and clinical sciences

وصف الملف: application/pdf

URL الوصول: https://escholarship.org/uc/item/9kx2n7pp

المؤلفون: Li Shiqi, Zhang Jiasi, Chen Lvzhe, Xu Huailong, He Liping, Liu Lin, Zhang Qianzhen, Yuan Zhongtao, Shen Junjie, Chen Zucong, Zhang Yingzi, Wang Meiling, Li Yunyan, Wang Linling, Fang Lihua, Chen Yingnian, Zhu Wei, Li Yu, Luo Le, Wang Youcheng, Zhang Dingsong, Dong Yancheng, Yin Ping, Zhang Lihua, Li Xiaoping, Hu Xiaozhuang, Zheng Zhongzheng, Yang Zhi, Qian Cheng, Wang Sanbin

المصدر: Molecular Therapy: Oncolytics, Vol 29, Iss , Pp 107-117 (2023)

مصطلحات موضوعية: CAR-T, persistence, durable remission, acute lymphoblastic leukemia, memory T cell, long-term remission, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

وصف الملف: electronic resource

Relation: http://www.sciencedirect.com/science/article/pii/S2372770523000281; https://doaj.org/toc/2372-7705

URL الوصول: https://doaj.org/article/7201ac7e65644bdd9f41d9b323f0db6b

مرشدي الرسالة: UAM. Departamento de Medicina

المصدر: Case Reports in Oncology 5 (2012): 676-681
1662–6575
676
3
681
5

مصطلحات موضوعية: Bevacizumab, Cetuximab, Durable remission, Glioma, Medicina

URL الوصول: http://hdl.handle.net/10486/663033

المؤلفون: Dalia Kaakour, Garrett Ward, Farshid Dayyani

المصدر: Diseases, Vol 10, Iss 2, p 24 (2022)

مصطلحات موضوعية: checkpoint inhibitors, advanced gastric cancer, survival, durable remission, Medicine

وصف الملف: electronic resource

Relation: https://www.mdpi.com/2079-9721/10/2/24; https://doaj.org/toc/2079-9721

URL الوصول: https://doaj.org/article/585d8ee009d142d392bde3d2064e7a46

المؤلفون: Jovanovic D, Stevic R, Velinovic M, Kontic M, Maric D, Spasic J, Radosavljevic D

المصدر: OncoTargets and Therapy, Vol Volume 10, Pp 4347-4354 (2017)

مصطلحات موضوعية: lung adenocarcinoma, erlotinib, exon 19 deletion, EGFR, durable remission, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

وصف الملف: electronic resource

Relation: https://www.dovepress.com/durable-complete-remission-of-poor-performance-status-metastatic-lung--peer-reviewed-article-OTT; https://doaj.org/toc/1178-6930

URL الوصول: https://doaj.org/article/e268d527adf4404ab9f0b534d8cd1d13

المؤلفون: Balakrishnan, Nikhil^Aff2

المساهمون: Balakrishnan, Nikhil^Aff1

المصدر: Dependability in Medicine and Neurology : Using Engineering and Management Principles for Better Patient Care. :261-293

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

المؤلفون: Joan Manel Gasent Blesa, Sara Blasco Mollá, María Fonfría Esparcia, JoséMiguel Sempere Ortells, Miguel Peris Godoy, Adrian Munilla Das, Balbino Mancheño Magan, Mariano Provencio Pulla, Jose Luis Sanchez, Juan Bautista Laforga Canales, Vicente Alberola Candel

المصدر: Case Reports in Oncology, Vol 5, Iss 3, Pp 676-681 (2012)

مصطلحات موضوعية: Glioma, Durable remission, Bevacizumab, Cetuximab, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

وصف الملف: electronic resource

Relation: http://www.karger.com/Article/FullText/341852; https://doaj.org/toc/1662-6575

URL الوصول: https://doaj.org/article/e3815badee514242a3b5fc23ae191ff7

المؤلفون: Jelena Spasic, Ruza Stevic, Dragana Jovanovic, Marta Velinovic, Milica Kontic, Dragana Maric, Davorin Radosavljevic

المصدر: OncoTargets and therapy
OncoTargets and Therapy, Vol Volume 10, Pp 4347-4354 (2017)

مصطلحات موضوعية: 0301 basic medicine, Oncology, medicine.medical_specialty, erlotinib, medicine.drug_class, EGFR, Case Report, lcsh:RC254-282, Tyrosine-kinase inhibitor, Metastasis, durable remission, 03 medical and health sciences, T790M, 0302 clinical medicine, Internal medicine, Medicine, Pharmacology (medical), Epidermal growth factor receptor, biology, business.industry, medicine.disease, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, lung adenocarcinoma, Gemcitabine, 3. Good health, 030104 developmental biology, exon 19 deletion, Response Evaluation Criteria in Solid Tumors, 030220 oncology & carcinogenesis, biology.protein, Adenocarcinoma, Erlotinib, business, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fcbe9cc2b0cd0b152886a2b85783f341
http://europepmc.org/articles/PMC5593392